Why the study?
Does lipid feeding increase apoA-I synthesis in the intestinal mucosa of normal subjects and patients with Tangier disease?
Does lipid feeding increase apoA-I synthesis in the intestinal mucosa of normal subjects and patients with Tangier disease?
The low levels of apoA-I in Tangier disease are not due to a failure of intestinal synthesis but likely result from abnormal metabolism of chylomicron apoproteins.
Answers are grounded in this paper and cite their sources.
May indicate preserved intestinal apoA-I synthesis in Tangier disease; leaves open defective chylomicron metabolism as cause and requires confirmation.
To determine whether human small intestine synthesizes apoA-I, the major apoprotein of plasma high-density lipoproteins, we used immunofluorescence technics and monospecific antiserums to visualize apoA-I within intestinal epithelial cells from four normal subjects and one patient with Tangier disease. Biopsies from all subjects during fasting showed limited fluorescence. After lipid feeding intracellular apoA-I markedly increased in both normal subjects and the patient. During alimentary lipemia, mean plasma apoA-I levels (milligrams per deciliter) increased in four normal subjects from 161 +/- 12 (+/- S.E.M.) to 180 +/- 15 (P less than 0.05) and in the patient from 1.9 to 6.8. Normal plasma chylomicrons contained apoB, apoE and the C peptides but not apoA-I. The patient's chylomicrons contained ap0A-I. Normal and Tangier-disease intestinal-mucosa cells increase their content of apoA-I during chylomicron formation and subsequently contribute to plasma apoA-I levels. The low levels of apoA-I in Tangier disease are not due to a failure of intestinal synthesis but might be due to abnormal metabolism of chylomicron apoproteins.
No takes yet. Share an insight, caveat, or question.
Glickman et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: